Confocal Microscopy Dual Band in the Management of Bladder Cancer (HEXVISIO)

Lille Catholic University

Status: Completed

Conditions: Urinary Bladder Neoplasm

Treatments: Device: Cellvizio dual band

Study type: Observational

Funder types: Other

Identifiers

NCT02857634

RC-P0035

Details and patient eligibility

About

Bladder cancer is one of the most common cancer worldwide and the second most frequent urological cancer. The photodynamic diagnosis technique (PDD) currently used (Hexvix®) has improved tumor detection but with a high false positive rate. Indeed, the main limitation of the PDD is its lack of specificity, ranging from 35 to 66%. The association of this technique with new technologies such as the Cellvizio Dual Band featuring simultaneous dual wavelength illumination and detection, could improve the identification of tumoral lesions. The objective of this study is to demonstrate the efficacy of Cellvizio dual band technique for the diagnosis of tumors bladders.

Enrollment: 3 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients having 18 years old or more
• Patients with a bladder carcinoma and with indication of tumor resection under Hexvix procedure.
• Patients giving consent to participate in the study

Exclusion criteria

-No consent to participate in the study

Trial design

3 participants in 1 patient group

Bladder tumor resection

Treatment:

Device: Cellvizio dual band